Thyrocare Technologies
THYROCARE · Healthcare > Hospital & Healthcare Services · Chairman: A Velumani · MD: Dharmil Sheth · Listing date: May 10, 2016 · Employees: 1582 · Navi Mumbai · http://www.thyrocare.com

Stock Price vs Company Growth
1d
4.8%
1w
22.6%
1m
25.7%
3m
20.6%
6m
5.7%
1y
65.8%
5y
9.2%
all
11.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 491 4.8%
343
526
Company Overview

Sales
829 Cr
Growth: 17.8%
Profit after Tax
163 Cr
Growth: 18.5%
Mid Cap
7,816 Cr
P/E: 48.3x
Industry P/E: 51.2x
Fundamentals

Sales (Cr) ₹ 829
Growth 17.8%
EBITDA 31.6%
P/S 9.5x
Dividend 2.1%
P/E 48.3x
Book Value ₹ 36.8
PEG Ratio 2.7x
ROE 25.3%
P/B 13.5x
Shareholding Pattern

Institutions
Arisaig Asia Consumer Fund Limited
6.11 %
Nippon Life India Trustee Ltd-A/C Nippon India Nifty Small Cap 250 Index Fund
3.57 %
Fundsmith Emerging Equities Trust Plc
1.46 %
Promoters
Dr.A.Velumani
28.02 %
Thyrocare Publications Llp
12.36 %
Thyrocare Properties And Infrastructure Private Imited
9.88 %
A.Sundararaju Huf
4.57 %
Sumathi Infra Project Llp
2.98 %
Others
Bakak Financial Securities
2.84 %
Llp
0.13 %
Increase    Decrease    No change
Company Profile Detailed

Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.
Investors (96)
Followers (24)